Spots Global Cancer Trial Database for Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
Official Title:
Study ID: NCT00832689
Conditions
Interventions
Study Description
Brief Summary: The study hypothesis is that chemotherapy of irinotecan and gemcitabine will improve local control of cancer and prolong survival in patients with inoperable biliary tract cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 17 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Severance hospital, Seoul, , Korea, Republic of
Contact Details
Name: Jeong Youp Park, MD
Affiliation: Assistant professor of division of Gastroenterology
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
